Actively Recruiting

Phase Not Applicable
Age: 18Years - 75Years
All Genders
ID05974358

KONO-S Anastomosis Compared to Conventional Ileocolonic Anastomosis to Reduce Recurrence in Crohn's Disease: a Superiority Phase III Prospective, Randomized, Multicenter, Double-blind Trial.

Led by Centre Hospitalier Universitaire de Besancon · Updated on 2025-02-13

226

Participants Needed

15

Research Sites

83 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are investigating Crohn's disease, a chronic inflammatory bowel disease that affects many people and often leads to serious digestive complications and a high rate of surgery. This research focuses on comparing two surgical techniques for ileocolonic resection to reduce the risk of disease recurrence after surgery. The study is a prospective, multicenter, randomized, double-blind trial aiming to provide stronger evidence on the effectiveness of the Kono-S anastomosis compared to the conventional method. The trial compares two surgical approaches: the Kono-S anastomosis, which is a specific type of ileocolonic connection designed to prevent distortion and narrowing, and the conventional side-to-side ileocolonic anastomosis. Patients undergoing their first ileocolonic resection for Crohn's disease will be randomly assigned to one of these two groups. The Kono-S technique has shown promise in reducing surgical recurrence rates in earlier studies, but this trial will offer a more rigorous evaluation with blinded and centralized assessments. Participants will be monitored over time with various assessments, including an endoscopy at 6 months to measure recurrence using a standardized score. Clinical activity will also be evaluated through indexes such as the Harvey-Bradshaw Index and Crohn's Disease Activity Index at 6, 12, 18, and 24 months, along with fecal calprotectin tests at 6 and 12 months. The study will help determine which surgical method better reduces disease recurrence and improves patient outcomes over the long term, with total participation lasting at least two years.

CONDITIONS

Brief Title

KONO-S Anastomosis Compared to Conventional Ileocolonic Anastomosis to Reduce Recurrence in Crohn's Disease

Who Can Participate

Age: 18Years - 75Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Adult patient 18 years and older up to 75 years
  • Diagnosed with Crohn's disease
  • Requiring a first ileocolonic resection due to fistulizing, abscessed, stenosing disease, or disease not responding to medical treatment
  • Affiliated to the French social security system
Not Eligible

You will not qualify if you...

  • Previous ileocolonic resection surgery
  • Contraindication to postoperative endoscopy
  • Planned anastomosis with a protective stoma
  • Emergency surgery due to peritonitis
  • Lack of consent to participate in the study
  • Pregnancy
  • Refusal or inability to provide informed consent
  • Patient under legal protection such as guardianship by court order

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Surgery and Immediate Post-operative Care

Duration - Day of surgery and immediate recovery period

Participants undergo either Kono-S anastomosis or conventional ileocolonic anastomosis surgery to treat Crohn's disease.

1 surgical procedure and immediate post-operative care visits

Post-operative Follow-up

Duration - Up to 24 months

Participants are monitored through clinical scores and endoscopy to assess recovery and recurrence of Crohn's disease.

Visits at 6, 12, 18, and 24 months including endoscopy and clinical assessments

Trial Site Locations

Total: 15 locations

1

CHu de Besançon

Besançon, France, 25030

Actively Recruiting

2

CHU de Bordeaux

Bordeaux, France

Not Yet Recruiting

3

CHU de Grenoble

Grenoble, France

Not Yet Recruiting

4

CHU de Lille Hopital Claude Huriez

Lille, France

Not Yet Recruiting

5

HCL-Hôpital Lyon Sud

Lyon, France

Not Yet Recruiting

6

AP-HM Hôpital Nord

Marseille, France

Not Yet Recruiting

7

CHU de Nançy

Nancy, France

Not Yet Recruiting

8

CHU de Nantes

Nantes, France

Not Yet Recruiting

9

Ap-HP Hopital St Louis

Paris, France

Not Yet Recruiting

10

AP-HP Hôpital Européen Georges Pompidou

Paris, France

Not Yet Recruiting

11

AP-HP Le Kremlin-Bicetre

Paris, France

Not Yet Recruiting

12

AP-HP St Antoine

Paris, France

Not Yet Recruiting

13

CHU de Rennes

Rennes, France

Not Yet Recruiting

14

CHU de Strasbourg HautePierre

Strasbourg, France

Not Yet Recruiting

15

CHU de Toulouse

Toulouse, France

Not Yet Recruiting

Loading map...

Research Team

Z

Zaher LAKKIS

A

Astrid POZET

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Similar Trials

Follow-up Study to Evaluate the Safety of ALLO-ASC-CD in the...

Crohn Disease

Actively Recruiting

2 locations

A Master Protocol for Phase 2, Randomized, Controlled Studie...

Colitis, Ulcerative

Actively Recruiting

72 locations

Israeli IBD Research Nucleus (IIRN) Consortium: COBMINDEX Go...

Crohn Disease

Actively Recruiting

4 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here